✓ 24/7 automatic processing of online orders
✓ Knowledgeable and professional Product & Technical Support
✓ Fast and reliable (re)-ordering
Cat. No. / ID: 676923
✓ 24/7 automatic processing of online orders
✓ Knowledgeable and professional Product & Technical Support
✓ Fast and reliable (re)-ordering
To ensure highest sensitivity, the ipsogen WT1 ProfileQuant Kit has been optimized to detect Wilm's tumor (WT1) and ABL gene transcripts and uses prediluted plasmid standards and primers and probe mixes (see figures Accurate detection of Wilm's tumor plasmid standards and Reliable detection of ABL plasmid standards).
The ipsogen WT1 ProfileQuant Kit is a ready-to-use kit for the detection of Wilm's tumor (WT1) gene transcripts using real-time PCR. The kit is based on the amplification and quantification of specific Wilm's tumor (WT1) gene transcripts, relative to ABL control gene expression, in total RNA isolated from patients with acute myeloid leukemia (AML). The kit provides high levels of specificity, sensitivity, and reproducibility. The ipsogen WT1 ProfileQuant Kit includes specific plasmids and primers and probe mixes for WT1 and ABL (see figures WT1 gene transcript and ABL control gene transcript). Included are 5 standard dilutions for Wilm's tumor (WT1) and 3 standard dilutions for ABL. Use of the standards enables accurate quantification of transcripts. These components have been validated together in the context of a collaborative study led by a group of experts from the European Leukemia Net (ELN) consortium.